VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 362 filers reported holding VANECK VECTORS ETF TR in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,960,112 | +94.1% | 159,952 | +68.4% | 0.51% | +71.7% |
Q3 2023 | $2,556,019 | -10.6% | 94,984 | +0.1% | 0.30% | -26.5% |
Q2 2023 | $2,858,312 | -11.9% | 94,929 | -5.3% | 0.40% | +9.5% |
Q1 2023 | $3,244,123 | +14.9% | 100,282 | +5.3% | 0.37% | +87.3% |
Q4 2022 | $2,822,262 | +14.5% | 95,218 | +35.2% | 0.20% | +15.2% |
Q1 2022 | $2,465,000 | +24.2% | 70,442 | +7.3% | 0.17% | +30.5% |
Q4 2021 | $1,985,000 | -0.1% | 65,648 | +3.6% | 0.13% | -0.8% |
Q3 2021 | $1,986,000 | +0.5% | 63,358 | +4.7% | 0.13% | -5.0% |
Q2 2021 | $1,976,000 | +23.4% | 60,501 | +33.5% | 0.14% | +12.1% |
Q1 2021 | $1,601,000 | +310.5% | 45,329 | +293.3% | 0.12% | +275.8% |
Q4 2020 | $390,000 | -8.0% | 11,525 | +1.9% | 0.03% | -19.5% |
Q3 2020 | $424,000 | -98.8% | 11,314 | +632.3% | 0.04% | -67.5% |
Q1 2017 | $36,258,000 | -7.8% | 1,545 | -8.1% | 0.13% | +869.2% |
Q3 2016 | $39,344,000 | +51.2% | 1,682 | -10.2% | 0.01% | +333.3% |
Q2 2016 | $26,028,000 | – | 1,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |